CUSIP 032724106 · who reports it, how much, and how much it matters to them
30 of the 720 hedge fund managers we track reported shares of Anaptysbio, Inc (Nasdaq: ANAB) on Form 13F for 30 June 2026. Between them they reported USD 887m. The largest position belongs to ECOR1 Capital, at USD 532m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | ECOR1 Capital3 funds on PPLI.com | USD 532m | 25.9% |
| 2 | Millennium Management6 funds on PPLI.com | USD 54m | 0.0% |
| 3 | 683 Capital Management2 funds on PPLI.com | USD 45m | 2.2% |
| 4 | Palo Alto Investors6 funds on PPLI.com | USD 41m | 5.6% |
| 5 | D. E. Shaw & Co.15 funds on PPLI.com | USD 36m | 0.0% |
| 6 | Apis Capital Advisors4 funds on PPLI.com | USD 34m | 3.3% |
| 7 | Sofinnova Investments1 fund on PPLI.com | USD 33m | 1.7% |
| 8 | Citadel Advisors32 funds on PPLI.com | USD 27m | 0.0% |
| 9 | Squarepoint Ops7 funds on PPLI.com | USD 22m | 0.0% |
| 10 | Two Sigma Investments35 funds on PPLI.com | USD 18m | 0.0% |
| 11 | Greenhaven Road Investment Management4 funds on PPLI.com | USD 12m | 7.5% |
| 12 | Irenic Capital Management7 funds on PPLI.com | USD 4.8m | 0.2% |
| 13 | Eversept Partners3 funds on PPLI.com | USD 4.7m | 0.2% |
| 14 | Renaissance Technologies13 funds on PPLI.com | USD 3.9m | 0.0% |
| 15 | Voloridge Investment Management6 funds on PPLI.com | USD 3.9m | 0.0% |
| 16 | Marshall Wace LLP84 funds on PPLI.com | USD 3m | 0.0% |
| 17 | Capital Fund Management S.A.12 funds on PPLI.com | USD 2.6m | 0.0% |
| 18 | Atom Investors1 fund on PPLI.com | USD 2.3m | 0.2% |
| 19 | Voleon Capital Management13 funds on PPLI.com | USD 2.1m | 0.0% |
| 20 | Aquatic Capital Management3 funds on PPLI.com | USD 2.1m | 0.1% |
| 21 | Tudor Investment Corporation10 funds on PPLI.com | USD 1.4m | 0.0% |
| 22 | Diametric Capital2 funds on PPLI.com | USD 1.1m | 0.1% |
| 23 | Brevan Howard Capital Management39 funds on PPLI.com | USD 900,000 | 0.0% |
| 24 | Verition Fund Management3 funds on PPLI.com | USD 506,000 | 0.0% |
| 25 | Lombard Odier Asset Management (USA)16 funds on PPLI.com | USD 500,000 | 0.1% |
| 26 | Verdad Advisers6 funds on PPLI.com | USD 236,000 | 0.2% |
| 27 | Mangrove Partners Im1 fund on PPLI.com | USD 235,000 | 0.0% |
| 28 | Rangeley Capital6 funds on PPLI.com | USD 202,000 | 0.2% |
| 29 | Persistent Asset Partners10 funds on PPLI.com | USD 38,813 | 0.0% |
| 30 | The Quarry1 fund on PPLI.com | USD 1,958 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | ECOR1 Capital | USD 532m | 25.9% |
| 2 | Greenhaven Road Investment Management | USD 12m | 7.5% |
| 3 | Palo Alto Investors | USD 41m | 5.6% |
| 4 | Apis Capital Advisors | USD 34m | 3.3% |
| 5 | 683 Capital Management | USD 45m | 2.2% |
| 6 | Sofinnova Investments | USD 33m | 1.7% |
| 7 | Eversept Partners | USD 4.7m | 0.2% |
| 8 | Irenic Capital Management | USD 4.8m | 0.2% |
| 9 | Verdad Advisers | USD 236,000 | 0.2% |
| 10 | Atom Investors | USD 2.3m | 0.2% |
Anaptysbio, Inc trades under the symbol ANAB on the Nasdaq. Its CUSIP, the code used on Form 13F, is 032724106.
30 of the 720 hedge fund managers PPLI.com tracks reported Anaptysbio, Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by ECOR1 Capital (USD 532m), Millennium Management (USD 54m), 683 Capital Management (USD 45m), Palo Alto Investors (USD 41m) and D. E. Shaw & Co. (USD 36m).
30 managers in our coverage reported it, and between them they run 351 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
ECOR1 Capital, where the position was 25.9% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Anaptysbio, Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.